[HTML][HTML] A deep learning model of tumor cell architecture elucidates response and resistance to CDK4/6 inhibitors
Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6is) have revolutionized breast cancer
therapy. However,< 50% of patients have an objective response, and nearly all patients …
therapy. However,< 50% of patients have an objective response, and nearly all patients …
A deep learning model of tumor cell architecture elucidates response and resistance to CDK4/6 inhibitors
S Park, E Silva, A Singhal, MR Kelly, K Licon… - Nature … - pubmed.ncbi.nlm.nih.gov
Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6is) have revolutionized breast cancer
therapy. However,< 50% of patients have an objective response, and nearly all patients …
therapy. However,< 50% of patients have an objective response, and nearly all patients …
A deep learning model of tumor cell architecture elucidates response and resistance to CDK4/6 inhibitors.
S Park, E Silva, A Singhal, MR Kelly, K Licon… - Nature Cancer, 2024 - europepmc.org
Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6is) have revolutionized breast cancer
therapy. However,< 50% of patients have an objective response, and nearly all patients …
therapy. However,< 50% of patients have an objective response, and nearly all patients …